177Lu-R11228

N/A

Report date: 2025/11/28 15:16:14

NME

Base Information

Drug Name177Lu-R11228

Drug Alias Name177Lu-R11228

ClassificationSmall molecules > Heterocyclic drugsRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Nuclides > Lutetium > 177Lu +[4]

Mechanisms of ActionPositron-emission tomography enhancers

TargetsUpdating

Therapy Area/IndicationsHR-positive breast cancerBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesAustralia

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesRadionetics Oncology Inc

China Registration ClassN/A

Develop Information

Active CompaniesRadionetics Oncology Inc

Inactive CompaniesN/A

Active IndicationsHR-positive breast cancerBreast Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A